August 21, 2014
August 20, 2014
August 19, 2014
August 18, 2014
FDA Issues Draft Guidance on Medical Device Reporting for Manufacturers
The FDA recently issued a lengthy draft guidance titled “Medical Device Reporting for Manufacturers.” Similar to the related regulations, found at 21 C.F.R. § 803, the draft guidance discusses the requirements for reporting adverse events related to medical devices in a question and answer format. The draft guidance even converts the definitions of 21 C.F.R. § 803.3, which are crucial to understanding the reporting obligations, into a question and answer format. Thus, much of the draft guidance will be familiar to those who deal with the existing regulations on a regular basis.
For example, the draft guidance identifies the following basic requirements of manufacturers with respect to device reporting:
To submit to FDA reports of MDR reportable events involving their medical devices
To develop, maintain, and implement written procedures for the identification and evaluation of all adverse medical device events to determine whether the event is an MDR reportable event; and,
To establish and maintain complete files for all complaints concerning adverse medical device events.
In this connection, the draft guidance summarizes the definition of a reportable event as an event that “manufacturers become aware of that reasonably suggests that one of their marketed devices may have caused or contributed to a death or serious injury, or has malfunctioned and the malfunction of the device or a similar device that they market would be likely to cause or contribute to a death or serious injury if the malfunction were to recur.”
The second half of the draft guidance, which addresses what to do in specific situations and specific questions about completing FDA Form 3500A in connection with a report, is likely to be of more interest to those already familiar with the regulations. Some of the issues addressed in this part of the draft guidance include:
Whether a delay in surgery related to a device is a reportable event
How to determine the expected life of a device
Whether events already mentioned in the labeling are reportable
Whether an event indirectly caused by a failed diagnostic device is reportable
Whether an event is reportable when there is a conflict in medical opinion as to whether the device contributed to the event
How to report adverse events involving the same patient and device but occurring on different days
The amount of effort required for a follow-up investigation
Whether an event is reportable if the device is being used under an IDE
The reportability of events occurring outside the U.S.
Whether a manufacturer has an obligation to submit a report when it has ceased marketing the device
Whether a manufacturer must investigate and submit a report on an event it becomes aware of through literature
A copy of the draft guidance can be found here.
<span class="advertise"> Advertisement </span>
- Massive Data Breach Affects 4.5 Million Patients in 29 States
- NLRB Continues to Expand its Reach
- The OIG Issues An OIG Rule on ACOs and the IRS Provides Additional Guidance For Tax-Exempt Organizations
- FDA Issues Final Guidance on "In Vitro Companion Diagnostic Devices"
- CMS Care Coordination Payments – A Boon to Doctors and Patients but Patient Participation Will be Essential
- OSHA Concludes that Acclimatization May Be the Most Important Element of a Heat-Illness Prevention Program